ASA in the News
University of Maryland’s School of Pharmacy Offers Training for Medical Marijuana - Americans for Safe Access
By Michelle Harris for Baltimore Magazine
The school is partnered with a Washington D.C.-based nonprofit to create online programming.
The Center for Innovative Pharmacy Solutions (CIPS) at the University of Maryland School of Pharmacy in Baltimore has begun offering training for workers in the medical marijuana industry. The patient-focused certification training (PFC), which launched on July 1, provides professional instruction and educational standards to a growing national industry that struggles with evolving regulations and science.
University of Maryland's School of Pharmacy creates program on medical marijuana - Americans for Safe Access
By Richard Reeve for ABC7 WJLA
COLLEGE PARK, Md. (ABC7) — Medical marijuana training is now part of the curriculum at the University of Maryland.
The School of Pharmacy in Baltimore has already signed up 24 people for online courses and hopes to signs thousands more.
"Let's educate these individuals to do it properly, says pharmacy Professor Magaly Rodriguez de Bittner. "The training is specifically geared toward the staff, that by the Maryland law, are going to be dispensing or cultivating the medical marijuana."
University of Maryland School of Pharmacy takes on training for medical marijuana - Americans for Safe Access
By Meredith Cohn for The Baltimore Sun
The pharmacy school's partnership with Americans for Safe Access gives the nonprofit advocacy group "immediate legitimacy" for its courses, said Shad Ewart, a professor at Anne Arundel Community College, who teaches a course about the marijuana industry for credit but not yet industry certification.
He said the school also benefits because officials there had to do little leg work in developing a curriculum that could have taken months or years to produce on their own. (University officials said they reviewed the content and made it conform to educational norms.)
Reintroduced CARERS Act Would Protect States' Rights, Medical Marijuana Patients - Americans for Safe Access
By Thomas Mitchell for Westword
Days after a letter from Attorney General Jeff Sessions surfaced, asking congressional leaders to revoke federal protections for medical marijuana, senators have introduced a bill that would protect medical marijuana patients in states where it's legal while also removing cannabidiol (CBD) from the Controlled Substances Act and expanding research on marijuana.
By the Associated Press for WTOP
No other U.S. state is taking the research-before-legislation route because they realize it is futile, said Jahan Marcu of Americans for Safe Access, a national medical cannabis advocacy group.
“It’s never been shown to work in the past, so we are not confident that it’s going to serve the needs of patients,” he said of the process.
By Maui Now
Hawaiʻi Department of Health has received a “B” and was ranked the fifth highest in the nation for its medical marijuana program, based on a recent report card of new, regulated medical marijuana distribution programs issued by Americans for Safe Access.
The national organization’s mission is to reduce barriers to medical cannabis by creating policies to improve access for patients and researchers, using legislation, education, litigation, research and other means.
According to the report card, “Hawaiʻi is on track to become one of the best programs in the country if they continue with their timely implementation.”
By Steph Sherer for The Hill
The phrase “no news is good news” should mean an assurance that a situation is not dramatically worsening, and perhaps even improving. For the first 100 days of Trump’s Presidency, the lack of news surrounding medical cannabis has been, for the most part, good news for the status quo. However, this is not a comfort to medical cannabis patients for whom behind the scenes actions could upend, disrupt, or delay access to their medication.
By Francisco Alvarado for Vice
“Whether or not doctors or other health care professionals have any intention of recommending medical cannabis for patient care, they all need to be well educated in this clinical area because their patients will be seeking their expert advice and guidance for this medication,” noted Stephen B. Corn, MD, a specialist in anesthesiology, perioperative and pain medicine at Brigham and Women’s Hospital and Children’s Hospital, both in Boston. Since patients may already be using medical marijuana, clinicians “need to be aware of the physiological effects of cannabis as well as potential drug interactions and side effects,” Dr. Corn added, stressing that expertise in medical cannabis will be necessary for most doctors, pharmacists, nurses and other health care professionals.
For CBS Miami
“When we look at tools to combat the opioid crisis, I think it’s amazing that medical cannabis is a tool we can use. At the heart of all of our challenges is the fact that the federal government sees cannabis as more dangerous than methamphetamines or cocaine.” - Steph Sherer